Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Paclitaxel in Elderly Urothelial Cancer
NCT00022633Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 2001
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, paclitaxel in urothelial carcinoma (UC), sponsored by SWOG Cancer Research Network. Started Jul 2001; status: terminated.
02
Drugs
gemcitabinepaclitaxel
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00022633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022633.